Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Reduced expression of the rplU-rpmA ribosomal protein operon in mexXY-expressing pan-aminoglycoside-resistant mutants of pseudomonas aeruginosa.

Lau CH, Fraud S, Jones M, Peterson SN, Poole K.

Antimicrob Agents Chemother. 2012 Oct;56(10):5171-9. doi: 10.1128/AAC.00846-12.

2.

Antibiotic inducibility of the mexXY multidrug efflux operon of Pseudomonas aeruginosa: involvement of the MexZ anti-repressor ArmZ.

Hay T, Fraud S, Lau CH, Gilmour C, Poole K.

PLoS One. 2013;8(2):e56858. doi: 10.1371/journal.pone.0056858.

3.

Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa.

Guénard S, Muller C, Monlezun L, Benas P, Broutin I, Jeannot K, Plésiat P.

Antimicrob Agents Chemother. 2014;58(1):221-8. doi: 10.1128/AAC.01252-13. Erratum in: Antimicrob Agents Chemother. 2014 Mar;58(3):1833.

4.
6.

AmgRS-mediated envelope stress-inducible expression of the mexXY multidrug efflux operon of Pseudomonas aeruginosa.

Lau CH, Krahn T, Gilmour C, Mullen E, Poole K.

Microbiologyopen. 2015 Feb;4(1):121-35. doi: 10.1002/mbo3.226.

7.

A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa.

Muller C, Plésiat P, Jeannot K.

Antimicrob Agents Chemother. 2011 Mar;55(3):1211-21. doi: 10.1128/AAC.01252-10.

8.

Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.

Chuanchuen R, Wannaprasat W, Ajariyakhajorn K, Schweizer HP.

Microbiol Immunol. 2008 Aug;52(8):392-8. doi: 10.1111/j.1348-0421.2008.00051.x.

9.

Primary mechanisms mediating aminoglycoside resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7.

Morita Y, Tomida J, Kawamura Y.

Microbiology. 2012 Apr;158(Pt 4):1071-83. doi: 10.1099/mic.0.054320-0.

PMID:
22282519
10.

Mutational activation of the AmgRS two-component system in aminoglycoside-resistant Pseudomonas aeruginosa.

Lau CH, Fraud S, Jones M, Peterson SN, Poole K.

Antimicrob Agents Chemother. 2013 May;57(5):2243-51. doi: 10.1128/AAC.00170-13.

11.

Functional characterization of MexXY and OpmG in aminoglycoside efflux in Pseudomonas aeruginosa.

Chuanchuen R, Wannaprasat W, Schweizer HP.

Southeast Asian J Trop Med Public Health. 2008 Jan;39(1):115-22.

PMID:
18567450
12.
13.
14.
15.

Role of MexZ and PA5471 in transcriptional regulation of mexXY in Pseudomonas aeruginosa.

Yamamoto M, Ueda A, Kudo M, Matsuo Y, Fukushima J, Nakae T, Kaneko T, Ishigatsubo Y.

Microbiology. 2009 Oct;155(Pt 10):3312-21. doi: 10.1099/mic.0.028993-0.

PMID:
19589837
16.

Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression.

Caughlan RE, Sriram S, Daigle DM, Woods AL, Buco J, Peterson RL, Dzink-Fox J, Walker S, Dean CR.

Antimicrob Agents Chemother. 2009 Dec;53(12):5015-21. doi: 10.1128/AAC.00253-09.

17.

Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System.

Poole K, Lau CH, Gilmour C, Hao Y, Lam JS.

Antimicrob Agents Chemother. 2015 Dec;59(12):7276-89. doi: 10.1128/AAC.01785-15.

18.

Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously.

Llanes C, Hocquet D, Vogne C, Benali-Baitich D, Neuwirth C, Plésiat P.

Antimicrob Agents Chemother. 2004 May;48(5):1797-802.

19.

Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa.

Islam S, Jalal S, Wretlind B.

Clin Microbiol Infect. 2004 Oct;10(10):877-83.

Items per page

Supplemental Content

Support Center